Biopsych w7-12 Neurogenetics, psychopharmacology, Placebo, Other Neurotransmitters, Serotonin and Mood Disorders, Noradrenaline,

Description

Psychology Quiz on Biopsych w7-12 Neurogenetics, psychopharmacology, Placebo, Other Neurotransmitters, Serotonin and Mood Disorders, Noradrenaline,, created by Taylor Carre-Riddell on 20/04/2017.
Taylor  Carre-Riddell
Quiz by Taylor Carre-Riddell, updated more than 1 year ago
Taylor  Carre-Riddell
Created by Taylor Carre-Riddell almost 7 years ago
11
0

Resource summary

Question 1

Question
What is a polymorphism?
Answer
  • A portion of the protein that atttches to a dna
  • The range of alleles in genes
  • a discontinuous genetic variation resulting in the occurrence of several different forms or types of individuals among the members of a single species. A discontinuous genetic variation divides the individuals of a population into two or more sharply distinct forms
  • a categorical genetic variation resulting in the occurrence of several different forms or types of individuals among the members of a single species. A categorical genetic variation divides the individuals of a population into two or more sharply distinct forms

Question 2

Question
What is a GWAS?
Answer
  • None of the below
  • A genetic marker for unknown genes at a particular loci
  • n examination/placing of markers on an genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait. Can test traits/disorders. Use strand of interest to attach to target strand portion in chromosone. A Manhattan plot
  • n examination/placing of markers on an genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait. Can only be used to karotype

Question 3

Question
DNA varients include:
Answer
  • Single nucleotide subsitution Structural- has potentional changes (helix etc) shape
  • Single nucleotide subsitution Structural- has potentional changes (helix etc) shape Deletion of half a codon on sister strand- any number of bases
  • Single nucleotide subsitution Structural- has potentional changes (helix etc) shape Deletion of half a codon on sister strand- any number of bases Nucleotide substitution- number of bases
  • Single nucleotide subsitution Structural- has potentional changes (helix etc) shape Deletion of half a codon on sister strand- any number of bases Nucleotide substitution- number of bases Block inversion nucleotides backwards on the sister strand - held together by H bonds Copy number- the number of repeating sequences (eg codons) can either increase or decrease, changing protein structure

Question 4

Question
Most phenotype causes and changes are...
Answer
  • Monogentic
  • Polygenetic

Question 5

Question
A disadvantage in genochips:
Answer
  • Can't be sure that SNP variance, if found in tests, accounts for malfunction in gene
  • costly to run
  • need ill patients

Question 6

Question
what is the adv of Endophenotypes?
Answer
  • use healthy patients.
  • single out quantitative traits
  • cheap to run
  • A and B

Question 7

Question
What kind of studies are animals useful for?
Answer
  • Longitudinal studies
  • All kinds: their genome is comparative to humans
  • Meta analysis
  • Repeated Measures

Question 8

Question
How are animals used in gene studies?
Answer
  • Mutagenetics
  • Crossing animals
  • same as human dna study techniques
  • all of the above

Question 9

Question
Foward and Reverse Genetic study modules entail:
Answer
  • Mean the same thing: its just current or past time periods
  • Genotype to work out phenotype
  • Phenotypes work out genotype
  • B and C

Question 10

Question
Casual links between genes, brain chemistry and behaviour can be determined by:
Answer
  • GWAS
  • Observing modes of inheritance with specific traits
  • Observing Phenotypes, mutating different genes and observing the functional, structural and behavioural impact
  • All of the above

Question 11

Question
The two types of post synaptic receptors are:
Answer
  • Positvely and negatively charged
  • Channel and carrier mediated
  • Ion Channels G-Protein coupled
  • none of the above

Question 12

Question
Neuromodulation:
Answer
  • all of the below
  • Presynaptic: Alters neurotransmitter release Postsynaptic: Alters neurotransmitter action (e.g., alters excitability/ firing pattern)
  • -Neuromodulation may produce both neurophysiological and biochemical effects. Some moles can be NTs and modulators depending on context eg Serotonin
  • Describes slower (milliseconds to seconds) processes that alter the subsequent responsiveness of neurons.

Question 13

Question
Why is the criteria for Defining Neurotransmitters not set?
Answer
  • The research is not comprehensive enough
  • Too many variables to consider
  • Same mol somewhere else doesnt act as NT elsewhere
  • none of the above

Question 14

Question
The difference between neuromodulation ad neurotransmission is:
Answer
  • Neurotransmission: Either EXCITATORY or INHIBITORY and serves rapid (millisecond), precise, point to point communication. Neuromodulation: Describes slower (milliseconds to seconds) processes that alter the subsequent responsiveness of neurons.
  • Neuromodulation: Either EXCITATORY or INHIBITORY and serves rapid (millisecond), precise, point to point communication. Neurotransmission: Describes slower (milliseconds to seconds) processes that alter the subsequent responsiveness of neurons.
  • Synthesis and transport to the synapse is relatively slow. BUT The neurotransmitter action is extremely fast because it sits ready for release.
  • A and C

Question 15

Question
Psychopharmacology, the drugs either behave as:
Answer
  • Antagonist: gonists: act like NT on receptor Agonist: blocks receptor
  • Agonists: act like NT on receptor Antagonist: blocks receptor
  • Drugs act by “mimicking” natural neurotransmitters or neuromodulators in both cases
  • all of the above

Question 16

Question
A Nocebo is :
Answer
  • All of the below depending on intervention type
  • Beneficial effects attributable to the brain/mind responses to context of treatment (drug or device) delivery rather than its direct action. - Pain relief - Reduced distress - Other symptom relief
  • Negative effects attributable to the brain/mind responses to context of treatment delivery rather than drug action. - Pain - Nausea - Distress -Hormone/Immune Response
  • Depends on the drug being tested

Question 17

Question
From the medical perspective it is extremely important to disentangle placebo effects from the primary intervention because:
Answer
  • to develop the best treatments
  • to understand the actual effects of the intervention
  • What is caused by the placebo vs the pathology ie disentangle placebo effects from the primary intervention )
  • All of the above

Question 18

Question
The placebo intervention (the treatment context) works by:
Answer
  • actively interpreted by the brain and can elicit expectations, memories and emotions.. which can lead to symptom improvement
  • Tricking the patient as a way to cheapen research costs
  • Depending on the symptom and the type of “treatment” many different factors might be involved
  • None of the above

Question 19

Question
Benefits of placebo effects include:
Answer
  • Reduce drug intake
  • large or larger than accepted drug treatments and can reduce disability and increase quality of life over a period of months or longer (even reduce mortality).
  • Participants learned to control their brain activity and reported reduced chronic pain symptoms after training
  • None of the above

Question 20

Question
Ways to control and measure placebo effects include:
Answer
  • Open vs Hidden Design
  • Parallel Group Design
  • Conditioning Design
  • All of the above

Question 21

Question
Serotonin functions include:
Answer
  • Acts as a neuromodulator influencing the activity of a variety of neurons throughout the brain
  • appetite, temperature, working memory, hallucinations and mood
  • sleep, arousal,
  • All of the above

Question 22

Question
Serotonin made by:
Answer
  • The Anterior pituarity gland
  • from neurons originating in the Raphe Nucleus (Raphe = midline).
  • Tryptophan an amino acid is activated upon by synethsis enyzme to form active compound.
  • B and C

Question 23

Question
The DSM criteria for depression
Answer
  • A At least 5 of the following symptoms (see slides) have been present during the same 2-week period; at least one of the symptoms is either B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. C. The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, a medication) or a general medical condition (e.g. hypothyroidism).
  • E. The symptoms are not better accounted for by Bereavement (loss of a loved one).
  • Brain imaging studies show a reduction in some types of serotonin receptors in the brain of unmedicated depressed patients.
  • All of the above

Question 24

Question
A key amino acid needed to make NA is:
Answer
  • Amino Acid decarboxylase
  • Tryrosine
  • Dopamine βAhydroxylase
  • All of the above

Question 25

Question
Tryptophan is:
Answer
  • mpaired serotonin function may be a “risk factor” leading to people being “vulnerable” to developing depression.
  • the serotonin building block
  • A lack of Tryptophan leads to reduced synthesis of serotonin
  • All of the above are correct

Question 26

Question
Serotonin Antidepressants (SSRI’s)
Answer
  • They reduce reuptake of transmitter from synaptic cleft. The breakdown enzyme is not enough to remove the excess.
  • Controversial to give to infants who are at risk of depression genetically, as it can affect the roles the nueromodulators play in the developing brains
  • ncreased levels of neurogenesis (birth of new brain cells) change or strengthen important mood related circuits in the brain. New evidence suggest SSRI’s could promote new brain cell growth treating past damage. May even be “neuroprotective”, protecting against future damage associated with depression
  • All of the above

Question 27

Question
Monoamine Oxidase Inhibitors (MAOIs) functions:
Answer
  • Blocks the breakdown of Serotonin (blocks the enzyme)
  • Can lead to lethal levels of serotonin and other neurotransmitters if ingested orally after people eat foods with too much
  • Now used as a last resort under strict control of diet and other medications.
  • None of the above

Question 28

Question
Imagine an artificial society in which all individuals are raised in perfectly controlled, identical environments. In this population:
Answer
  • the heritability of all traits will be high
  • the heritability of all traits will be zero;
  • heritability will of all traits will decrease throughout the lifespan;
  • heritability will be higher for physical traits than for behavioural traits.

Question 29

Question
An autosomal dominant trait is exhibited by a father, but not by a mother. Which of the following is most likely to be true?
Answer
  • Each of their offspring has a 50% chance of exhibiting the trait;
  • All daughters, but no sons, will exhibit the trait;
  • Each of their offspring has a 0% chance of exhibiting the trait.
  • All sons, but no daughters, will exhibit the trait;

Question 30

Question
Which of the following is NOT a feature of genome-wide association studies (GWAS)?
Answer
  • statistical criteria are usually very stringent, to account for multiple testing;
  • gene expression levels are quantified using microarrays;
  • imputation can be used to estimate genotypes that were not measured directly
  • modern studies test upwards of 500 000 genetic variants across the genome

Question 31

Question
Which of the following is NOT a type of structural genetic variant?
Answer
  • inversion;
  • copy number;
  • addition;
  • block substitution.

Question 32

Question
Endophenotypes have been used to study genetic contributions to psychological disorders. An endophenotype of a psychological disorder should be:
Answer
  • present only in individuals affected by the disorder;
  • responsive to the same drug therapies as the disorder;
  • likely to have a simpler genetic basis than the disorder;
  • all of the above

Question 33

Question
The genetic mutation underlying fragile X syndrome is most likely to be visible in a:
Answer
  • Manhattan plot;
  • karyotype map;
  • pedigree chart;
  • PET scan.

Question 34

Question
The CHRNA5-A3-B4 gene cluster encodes subunits of an acetylcholine receptor. Variants in this gene cluster are associated with both schizophrenia and:
Answer
  • amygdala reactivity;
  • abnormal eye movements;
  • visual sensitivity;
  • heavy smoking.

Question 35

Question
CRISPR-Cas9 technology is useful in:
Answer
  • forward-genetic studies;
  • reverse-genetic studies;
  • genome-wide association studies;
  • both (a) and (b).

Question 36

Question
High levels of LC/NA activity result in:
Answer
  • The larger the response of neurons in the Locus Coeruleus (LC), the more NA released & and the longer the following period of inhibition. In highly arousing situations the chosen focus of attention/behaviour dominates more for longer .. “distracting” alternatives are inhibited.
  • Highest rates rapidly follow a transient noxious or extremely positive stimulus/event (lots of NA released). 4F’s (Fight, Flight, Freeze or F… Fornicate
  • State of Hyperarousal adapted for evolutionarily important situations where “individual” or “sexual fitness” is involved.
  • All of the above

Question 37

Question
The CRISPR-Cas9 system:
Answer
  • was first observed in bacteria as a defence system against viruses;
  • contains RNA with the genetic code for the Cas9 protein;
  • uses the Cas9 protein to locate the desired DNA sequence;
  • all of the above.

Question 38

Question
Channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR) are different because:
Answer
  • ChR2 responds to blue light, while NpHR responds to yellow light;
  • activation of ChR2 suppresses neural firing, while NpHR induces neural firing;
  • ChR2 is more suited to CRISPR-Cas9, while NpHR is more suited to optogenetics;
  • all of the above.

Question 39

Question
The function of NA is:
Answer
  • Sympathetic nervous system (flight or fight) Arousal / Vigilance
  • Anxiety Exploitation vs Exploration
  • Reward / addiction memory consolidation
  • All of the above

Question 40

Question
At moderate levels of LC activity:
Answer
  • Noradrenaline acts to consolidate decisions.
  • inning desicion LARGER burst of NA release “tips the balance” in favor of the winner with MORE STRENGTH for the the neural pathway, supresses the others. Then the nuerons enter a brief refractory period
  • daptive behaviour represents a tradeoff between exploiting known sources of reward and exploring the environment for alternative sources of reward (food, water, sex etc).
  • All of the above

Question 41

Question
Pupil dilation:
Answer
  • dilation accompanies a switches during perceptual rivalry
  • dilate when select an image when the image is salient
  • can also be used as an index of cognitive decisions
  • All of the above
Show full summary Hide full summary

Similar

History of Psychology
mia.rigby
Biological Psychology - Stress
Gurdev Manchanda
Bowlby's Theory of Attachment
Jessica Phillips
Psychology A1
Ellie Hughes
Psychology subject map
Jake Pickup
Memory Key words
Sammy :P
Psychology | Unit 4 | Addiction - Explanations
showmestarlight
The Biological Approach to Psychology
Gabby Wood
Chapter 5: Short-term and Working Memory
krupa8711
Cognitive Psychology - Capacity and encoding
T W
Psychology and the MCAT
Sarah Egan